Post Reply to McGraw's Bench

This is not a vent board or any other kind of therapy. Before you hit the POST button, ask yourself if your contribution will add to the level of discussion going on.

Important notes on articles:

Handle:
Password:
Subject:

Message:

HTTP Link (optional):

Poster's Email (optional):

 


Post being replied to

Not entirely true -- I know first hand having run the by btd

largest drug safety consulting company in the world and having all top 50 pharmaceutical companies as my customers and hosting over 200 pharmaceutical company's safety database systems.

My company is (EDIT: was not -- I sold the company) not a healthcare provider nor are pharmaceutical companies considered to be healthcare porviders, yet we all had to adhere to HIPPA regulations (along with a pile of other ones -- especially when you do the union of every single law worldwide where an approved or phase 3 clinical product exists). It was an explicit part of every contract we entered into, part of the incredibly detailed and complex security audits we had to pass before a company could legally contract with us, etc.

Above said, your point still stands because if it is true players have signed a waiver upon accepting a scholarship at ND, then it is moot. The doctors employed by ND that are working with any athlete would legally be considered healthcare providers BTW - hence unable to disclose data to anyone sans a waiver allowing them to do it (so a coach could not get the info from the team doctor sans that waiver).

EDIT2: Also, those trainers and likely all coaches are going to likely be legally required to sign confidentiality agreements related to this matter. That CDA is what allows the doctor to then share information with them -- and for that matter is part of what lets the trainers diagnose injuries, etc. It then knits it all together all the way back to the HCP that is bound by HIPPA. It in effect is what trickled down to the pharmaceutical companies who then had to pass it down to every single vendor they interact with that can in any way access patient data (which the pharmaceutical companies get from the HCPs for every adverse event that is reported).